AU6930200A - Use of lentiviral vectors for antigen presentation in dendritic cells - Google Patents

Use of lentiviral vectors for antigen presentation in dendritic cells

Info

Publication number: AU6930200A
Authority: AU; Australia
Prior art keywords: dendritic cells; antigen presentation; lentiviral vectors; lentiviral; vectors
Prior art date: 1999-08-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU69302/00A

Inventor

June Kan-Mitchell

Xinqiang Li

Flossie Wong-Staal

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

University of California

Original Assignee

University of California

University of California Berkeley

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-08-27

Filing date

2000-08-23

Publication date

2001-03-26

2000-08-23 Application filed by University of California, University of California Berkeley filed Critical University of California

2001-03-26 Publication of AU6930200A publication Critical patent/AU6930200A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/19—Dendritic cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
- A61K40/24—Antigen-presenting cells [APC]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/46—Viral antigens
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
- A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the route of administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
- A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the dose, timing or administration schedule
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16041—Use of virus, viral particle or viral elements as a vector
- C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Biomedical Technology (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Biotechnology (AREA)
Chemical & Material Sciences (AREA)
Zoology (AREA)
Animal Behavior & Ethology (AREA)
Wood Science & Technology (AREA)
General Engineering & Computer Science (AREA)
Immunology (AREA)
Microbiology (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Hematology (AREA)
Virology (AREA)
Physics & Mathematics (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Plant Pathology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AU69302/00A 1999-08-27 2000-08-23 Use of lentiviral vectors for antigen presentation in dendritic cells Abandoned AU6930200A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US38471999A	1999-08-27	1999-08-27
US09384719		1999-08-27
PCT/US2000/023162 WO2001016342A1 (en)	1999-08-27	2000-08-23	Use of lentiviral vectors for antigen presentation in dendritic cells

Publications (1)

Publication Number	Publication Date
AU6930200A true AU6930200A (en)	2001-03-26

Family

ID=23518472

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU69302/00A Abandoned AU6930200A (en)	1999-08-27	2000-08-23	Use of lentiviral vectors for antigen presentation in dendritic cells

Country Status (4)

Country	Link
EP (1)	EP1214437A1 (en)
AU (1)	AU6930200A (en)
CA (1)	CA2392010A1 (en)
WO (1)	WO2001016342A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1141314A2 (en)	1998-12-31	2001-10-10	Chiron Corporation	Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
AU2002320314A1 (en)	2001-07-05	2003-01-21	Chiron, Corporation	Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
WO2004044147A2 (en) *	2002-11-07	2004-05-27	Lung-Ji Chang	Modified dendritic cells
CA2611056C (en)	2005-06-01	2016-06-28	California Institute Of Technology	Method of targeted gene delivery using viral vectors
BRPI0714495B8 (en)	2006-07-21	2021-05-25	California Inst Of Techn	Deficient lentivirus for pseudotyped recombinant replication
AU2010276194B2 (en)	2009-07-24	2012-02-02	Immune Design Corp	Lentiviral vectors pseudotyped with a Sindbis virus envelope glycoprotein
US9713635B2 (en)	2012-03-30	2017-07-25	Immune Design Corp.	Materials and methods for producing improved lentiviral vector particles
US8323662B1 (en)	2012-03-30	2012-12-04	Immune Design Corp.	Methods useful for generating highly mannosylated pseudotyped lentiviral vector particles comprising a Vpx protein
MX362699B (en)	2012-03-30	2019-02-01	Immune Design Corp	Lentiviral vector particles having improved transduction efficiency for cells expressing dc- sign.
US9493789B2 (en) *	2014-04-24	2016-11-15	Miltenyi Biotec Gmbh	Automated generation of genetically modified stem cells
EP3472281A4 (en)	2016-06-16	2020-02-19	Nuseed Pty Ltd	ELITE EVENT RAPS NS-B50027-4
GB202105278D0 (en) *	2021-04-13	2021-05-26	Imperial College Innovations Ltd	Cell therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU7158398A (en) *	1997-04-17	1998-11-11	Regents Of The University Of California, The	Use of lentiviral vectors for antigen presentation in dendritic cells

2000
- 2000-08-23 AU AU69302/00A patent/AU6930200A/en not_active Abandoned
- 2000-08-23 WO PCT/US2000/023162 patent/WO2001016342A1/en not_active Application Discontinuation
- 2000-08-23 CA CA002392010A patent/CA2392010A1/en not_active Abandoned
- 2000-08-23 EP EP00957722A patent/EP1214437A1/en not_active Withdrawn

Also Published As

Publication number	Publication date
WO2001016342A9 (en)	2002-09-19
EP1214437A1 (en)	2002-06-19
WO2001016342A1 (en)	2001-03-08
CA2392010A1 (en)	2001-03-08

Publication	Publication Date	Title
AU7158398A (en)	1998-11-11	Use of lentiviral vectors for antigen presentation in dendritic cells
AU5731400A (en)	2000-12-28	Methods of preparing electrochemical cells
AU1796601A (en)	2001-06-04	Methods of preparing electrochemical cells
AU2001259624A1 (en)	2001-11-20	Modulation of antigen processing using phagocytic cells
AU2002322211A1 (en)	2003-01-29	Methods and compisitions for activation human t cells in vitro
AU2001274920A1 (en)	2001-12-03	Mammalian receptor proteins; related reagents and methods
AU6140998A (en)	1998-08-25	Peptides and peptide-loaded antigen presenting cells for the activation of ctl
AU2001260847A1 (en)	2001-12-03	Compositions isolated from skin cells and methods for their use
AU4191600A (en)	2000-10-23	An eeprom cell on soi
AU5003600A (en)	2000-12-05	Charged membrane
AU6505299A (en)	2000-04-26	Methods for generating antigen-reactive t cells (in vitro)
AU2403901A (en)	2001-07-09	Maturation-promoting agent for immature dendritic cells
AU6930200A (en)	2001-03-26	Use of lentiviral vectors for antigen presentation in dendritic cells
AU2926000A (en)	2000-09-21	Packaging cells for retroviral vectors
AU2001233132A1 (en)	2001-08-07	Hybrid adeno-retroviral vector for the transfection of cells
AU2001292617A1 (en)	2002-03-26	Mammalian receptor genes and uses
AU1919201A (en)	2001-05-30	Mammalian receptor proteins; related reagents and methods
AU4642600A (en)	2000-11-02	Methods and compositions for use in potentiating antigen presentation by antigenpresenting cells
AU1796501A (en)	2001-06-04	Methods of preparing electrochemical cells
AU2977500A (en)	2000-08-25	Advanced antigen presentation platform
AU3916400A (en)	2000-10-09	Human transmembrane proteins
AU1618500A (en)	2000-05-29	Human cell surface receptor proteins
AU2001293074A1 (en)	2002-04-08	Human liver cell line
AU7308200A (en)	2001-04-30	Novel hev antigenic peptide and methods
AU2001286205A1 (en)	2002-03-26	Novel dendritic cell wall membrane and use thereof

Legal Events

Date	Code	Title	Description
2002-05-02	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase